These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36505452)

  • 1. Single-cell transcriptomics in bone marrow delineates CD56
    Melsen JE; van Ostaijen-Ten Dam MM; Schoorl DJA; Schol PJ; van den Homberg DAL; Lankester AC; Lugthart G; Schilham MW
    Front Immunol; 2022; 13():1044398. PubMed ID: 36505452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8
    Melsen JE; Lugthart G; Vervat C; Kielbasa SM; van der Zeeuw SAJ; Buermans HPJ; van Ostaijen-Ten Dam MM; Lankester AC; Schilham MW
    Front Immunol; 2018; 9():1829. PubMed ID: 30186282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
    Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
    Front Immunol; 2021; 12():640672. PubMed ID: 34017328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression.
    Pesce S; Squillario M; Greppi M; Loiacono F; Moretta L; Moretta A; Sivori S; Castagnola P; Barla A; Candiani S; Marcenaro E
    Front Immunol; 2018; 9():2360. PubMed ID: 30374356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
    Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
    J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD56
    Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J
    Front Immunol; 2017; 8():699. PubMed ID: 28674534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.
    Melsen JE; Lugthart G; Lankester AC; Schilham MW
    Front Immunol; 2016; 7():262. PubMed ID: 27446091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.
    Lugthart G; Melsen JE; Vervat C; van Ostaijen-Ten Dam MM; Corver WE; Roelen DL; van Bergen J; van Tol MJ; Lankester AC; Schilham MW
    J Immunol; 2016 Jul; 197(1):78-84. PubMed ID: 27226093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
    Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
    J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
    Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
    Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
    Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.
    Romagnani C; Juelke K; Falco M; Morandi B; D'Agostino A; Costa R; Ratto G; Forte G; Carrega P; Lui G; Conte R; Strowig T; Moretta A; Münz C; Thiel A; Moretta L; Ferlazzo G
    J Immunol; 2007 Apr; 178(8):4947-55. PubMed ID: 17404276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.
    Tarazona R; Casado JG; Delarosa O; Torre-Cisneros J; Villanueva JL; Sanchez B; Galiani MD; Gonzalez R; Solana R; Peña J
    J Clin Immunol; 2002 May; 22(3):176-83. PubMed ID: 12078859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.